Strimvelis for treating severe combined immunodeficiency caused by adenosine deaminase deficiency : an evidence review group perspective of a NICE Highly Specialised Technology evaluation

South, Emily orcid.org/0000-0003-2187-4762, Cox, Edward Miles, Meader, Nicholas orcid.org/0000-0001-9332-6605 et al. (2 more authors) (2019) Strimvelis for treating severe combined immunodeficiency caused by adenosine deaminase deficiency : an evidence review group perspective of a NICE Highly Specialised Technology evaluation. PharmacoEconomics - Open. pp. 151-161.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2018
Dates:
  • Accepted: 3 October 2018
  • Published: June 2019
  • Published (online): 17 October 2018
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 05 Oct 2018 09:50
Last Modified: 18 Oct 2019 23:22
Published Version: https://doi.org/10.1007/s41669-018-0102-3
Status: Published
Refereed: No
Identification Number: https://doi.org/10.1007/s41669-018-0102-3

Downloads

Filename: Strimvelis_paper_revised_clean.docx

Description: Strimvelis revised clean

Filename: South2018_Article_StrimvelisForTreatingSevereCom.pdf

Description: South2018_Article_StrimvelisForTreatingSevereCom

Share / Export

Statistics